Clinical Trial: Effect Of Sodium Glucose Co-Transporter-2 (SGLT-2) Inhibitors on Body Mass Index After 3 Months of Use in Diabetic Patients

U.S., Jan. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07367555) titled 'Effect Of Sodium Glucose Co-Transporter-2 (SGLT-2) Inhibitors on Body Mass Index After 3 Months of Use in Diabetic Patients' on Jan. 18.

Brief Summary: Total of 360 participants were enrolled and prescribed oral 200 mg SGLT-2 tablet. All participants were followed-up for about three months. Body mass index was measured before and after three months and mean change in BMI was assessed.

Study Start Date: Oct. 01, 2024

Study Type: INTERVENTIONAL

Condition: Diabete Mellitus

Intervention: DRUG: Oral 100 gram Empagliflozin tablet along with diet plan and exercise

oral 100 gram Empagliflozin tablet along with diet plan and exercise...